The most substantial differences exist for ER+/PR+ status followed by ER+ /PR– or ER–/PR+ status—indicating that lack of surgical treatment may also be a major factor for disparities in risk for breast cancer death. This evidence concerns the gene ESR1 and breast carcinoma.